Dyslipidemia, Lipoproteins, and Pharmacology: A Comprehensive Review

0.0(0)
studied byStudied by 1 person
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/156

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

157 Terms

1
New cards

What are the main components of lipoproteins?

Protein combined with:

  • Cholesterol

  • Triglycerides (TG)

  • phospholipids combined

2
New cards

Why do lipoproteins need to transport cholesterol and triglycerides?

Cholesterol and triglycerides are insoluble in plasma and require lipoproteins for transport.

3
New cards

What are the major classes of lipoproteins?

  • LDL (Low-Density Lipoproteins)

  • HDL (High-Density Lipoproteins)

  • VLDL (Very Low-Density Lipoproteins)

  • IDL (Intermediate Density Lipoprotein).

4
New cards

What is the role of cholesterol esters (CE) and triglycerides (TGs) in lipoproteins?

  • CE and TG are core components inside lipoproteins due to their lipophilic properties

  • Apolipoproteins are on the surface to interact with the environment.

5
New cards

What are the risk factors associated with dyslipidemia?

  • increased risk for Atherosclerotic Cardiovascular Disease (ASCVD)

  • nonfatal myocardial infarction (MI)

  • coronary heart disease (CHD)

  • stroke

6
New cards

What is Primary or Familial Dyslipidemia?

A genetic condition leading to increased risk of premature ASCVD due to significant elevations in cholesterol levels.

7
New cards

What causes Secondary or Acquired Dyslipidemia?

  • lifestyle choices

  • disease states

  • medications

  • diet

8
New cards

What defines Familial Hyperchylomicronemia?

Massive fasting hyperchylomicronemia with greatly elevated serum TG levels → often due to a deficiency of lipoprotein lipase (LPL).

9
New cards

What defines Familial Hypercholesterolemia?

Characterized by elevated LDL and normal VLDL levels due to a block in LDL degradation, leading to increased serum cholesterol.

10
New cards

What defines Familial Combined Hyperlipidemia?

Elevated VLDL and LDL levels resulting in increased serum TG and cholesterol levels → caused by overproduction of VLDL by the liver.

11
New cards

What is Familial Hypertriglyceridemia?

Increased VLDL levels with normal or decreased LDL levels, resulting in elevated circulating TG levels, often seen in obese and diabetic patients.

12
New cards

What is the role of bile acids in fat digestion?

Bile acids help break down dietary fats into micelles, facilitating the formation of free fatty acids (FFA).

<p>Bile acids help <u>break dow</u>n dietary fats into <u>micelles, </u>facilitating the <u>formation</u> of free fatty acids (FFA).</p>
13
New cards

What enzyme is responsible for breaking down triglycerides?

Pancreatic lipase.

14
New cards

What are the components of micelles?

  • free fatty acids (FFA)

  • 2-monoacylglycerides (2-MAG)

  • cholesterol

  • bile acids.

15
New cards

What are the component percentages of chylomicrons?

  • 85-90% triglycerides

  • 5-10% phospholipids

  • 1-3% cholesterol esters (CE)

  • 1-2% apolipoproteins (Apo) E & C2.

<ul><li><p><u>85-90% triglycerides</u></p></li><li><p>5-10% phospholipids</p></li><li><p>1-3% cholesterol esters (CE)</p></li><li><p>1-2% apolipoproteins (Apo) E &amp; C2.</p></li></ul><p></p>
16
New cards

How do chylomicron remnants contribute to lipid metabolism?

They bind to LDL receptors on the liver to synthesize cholesterol or transport fatty acids for storage.

17
New cards

What is the function of LDL receptors (LDL-R)?

LDL-R on the liver binds to LDL or chylomicron remnants for utilization in cholesterol synthesis.

<p>LDL-R on the liver binds to LDL <u>or chylomicron remnant</u>s for utilization in <u>cholesterol synthesis.</u></p>
18
New cards

What is the process of HDL synthesis?

ApoA1 helps form nascent HDL, which matures with the addition of FFA and Chol, aided by lecithin-cholesterol acyltransferase (LCAT).

<p><u>ApoA1</u> helps form <u>nascent HDL</u>, which <u>matures</u> with the addition of <u>FFA and Chol</u>, aided by lecithin-cholesterol acyltransferase <u>(LCAT)</u>.</p>
19
New cards

What is the role of lipoprotein lipase (LPL)?

LPL converts VLDL and IDL into FFA for storage in adipose tissue.

<p>LPL converts <u>VLDL and IDL</u> into <u>FFA for storage</u> in adipose tissue.</p>
20
New cards

How does LDL undergo cellular uptake?

LDL binds to LDLR on peripheral tissues, leading to endocytosis and lipolysis to form free cholesterol and fatty acids.

21
New cards

What is the first step of cholesterol synthesis?

the conversion of HMG-CoA to mevalonate by HMG-CoA reductase.

22
New cards

Why is LDL considered 'bad' cholesterol?

LDL can become oxidized in circulation, leading to foam cell formation and promoting atherosclerosis.

<p>LDL can become <u>oxidized in circulation</u>, leading to <u>foam cell formation</u> and <u>promoting atherosclerosis.</u></p>
23
New cards

What role do macrophages play in atherosclerosis?

Macrophages engulf oxidized LDL to form foam cells, contributing to plaque formation in arteries.

24
New cards

What triggers the conversion of LDL to oxidized LDL?

Oxidants (-OH, O2, etc.) and enzymes such as myeloperoxidase (MPO) convert LDL to oxidized LDL, which signals macrophages to remove excess LDL.

25
New cards

What is the composition of a thrombus?

  • platelets

  • coagulation factors

  • fibrin

  • side-note: can grow quickly to occlude arteries.

26
New cards

What enzymes are responsible for the removal of oxidized LDL?

  1. Paroxonase 1 (PON1)

  2. platelet activating factor acetyl hydrolase
    (PAF-AH).

27
New cards

What is the role of CD36 in macrophages?

CD36 allows for ox-LDL to be engulfed/internalized by the macrophage, leading to the formation of foam cells.

28
New cards

What is the mechanism of action of statins?

they are competitive inhibitors of HMG-CoA reductase, blocking the conversion of HMG-CoA to mevalonate, which decreases cholesterol synthesis.

29
New cards

What is the rate-limiting step of cholesterol synthesis?

The conversion of HMG-CoA to mevalonate by HMG-CoA reductase.

<p>The conversion of HMG-CoA to mevalonate by HMG-CoA reductase.</p>
30
New cards

What are the effects of statins on LDL-C levels?

  • decrease LDL-C by 50-60%

  • decrease triglyceride levels by 10-20%

  • increase HDL levels by 5-15%.

31
New cards

What are the indications for statin use?

they are indicated for dyslipidemia, primary prevention of cardiovascular disease, and secondary prevention of cardiovascular events.

32
New cards

Name two high-intensity statins and their doses.

  1. Atorvastatin (Lipitor): 40-80 mg

  2. Rosuvastatin (Crestor): 20-40 mg

33
New cards

What are the short-lived statins?

  • Fluvastatin (1-3 hr)

  • Lovastatin (3-4 hr)

  • Pravastatin (1-3 hr)

  • Simvastatin (2-3 hr).

34
New cards

What are the long-lived statins?

  • Atorvastatin (14-19 hr)

  • Pitavastatin (12 hr)

  • Rosuvastatin (20 hr).

35
New cards

What is a common adverse effect of statins?

  • Myalgia with normal CK levels

  • myopathy with moderate CK elevation

  • [rare] rhabdomyolysis with very high CK levels.

36
New cards

How can CoQ10 supplements help with statin-induced myalgia?

may alleviate myalgia by improving mitochondrial function in muscle fibers.

37
New cards

Which statins are metabolized by CYP3A4?

  • Lovastatin

  • Simvastatin

  • Atorvastatin

38
New cards

What are common drug interactions with statins?

  • Azole antifungals (e.g., Itraconazole)

  • macrolides (e.g., Erythromycin, Clarithromycin),

  • HIV protease inhibitors (e.g., Ritonavir)

  • grapefruit juice

39
New cards

What is the mechanism of PCSK9 inhibitors?

PCSK9 inhibitors block PCSK9 from degrading LDL receptors, increasing LDL receptor levels and decreasing LDL-C.

40
New cards

What are the effects of mAb and siRNA PCSK9 inhibitors?

  • mAb decreases LDL-C by 40-70%

  • siRNA decreases LDL-C by 50%.

41
New cards

What is the mechanism of MTP inhibitors?

block the conversion of triglycerides into pre-VLDL, preventing LDL-C formation.

42
New cards

What are the adverse effects of Lomitapide?

  • High incidence of hepatotoxicity

  • contraindicated in pregnancy

  • hepatic impairment.

43
New cards

What is the mechanism of Ezetimibe?

Ezetimibe blocks the uptake of cholesterol in the intestine → increasing LDL-R expression and decreasing LDL-C.

<p>Ezetimibe <u>blocks</u> the uptake of <u>cholesterol</u> in the intestine → <u>increasing</u> LDL-R <u>expression</u> and <u>decreasing LDL-C</u>.</p>
44
New cards

What are the drug interactions of Ezetimibe?

Bile acid sequestrants reduce the absorption of Ezetimibe → it should be administered at least 2 hours before or 4 hours after these agents.

45
New cards

What is the mechanism of Bempedoic acid?

inhibits ATP-Citrate Lyase, blocking the conversion of citrate to acetyl-CoA.

46
New cards

What are the effects of Bempedoic acid?

  • decreases LDL-C by 17% when used alone

  • 38% when combined with Ezetimibe.

47
New cards

What is the mechanism of bile acid sequestrants?

They bind to negatively charged bile acids in the intestine, preventing their reabsorption and promoting LDL uptake by the liver.

48
New cards

What are the adverse effects of bile acid sequestrants?

  • increased TG levels

  • constipation

  • malabsorption of fat-soluble vitamins.

49
New cards

What is the mechanism of fibric acids?

Fibric acids activate PPARα → increasing lipid metabolism and triglyceride lipolysis.

50
New cards

What are the effects of fibric acids?

  • decrease triglycerides by 20-50%

  • may modestly decrease LDL-C

51
New cards

What are the adverse effects of Niacin?

  • Flushing

  • pruritis

  • GI upset

  • increased uric acid levels

  • liver toxicity

  • increased blood sugar.

52
New cards

What are the effects of Omega-3 fatty acids for hyperlipidemia?

They help lower triglyceride levels and may improve overall lipid profiles.

53
New cards

What is the difference between systolic heart failure (HFrEF) and diastolic heart failure (HFpEF)?

  • HFrEF is characterized by decreased contractility and reduced ejection fraction

  • HFpEF involves stiff ventricles with preserved ejection fraction.

<ul><li><p>HFrEF is characterized by <u>decreased contractility</u> and <u>reduced ejection fraction</u></p></li><li><p>HFpEF involves <u>stiff ventricles</u> with <u>preserved ejection fraction.</u></p></li></ul><p></p>
54
New cards

What are common risk factors for diastolic heart failure?

  • Age

  • hypertension (HTN)

  • diabetes mellitus (DM).

55
New cards

What leads to pulmonary edema in heart failure?

Left ventricular (LV) failure.

56
New cards

What leads to systemic or peripheral edema in heart failure?

Right ventricular (RV) failure.

57
New cards

What factors determine cardiac output (CO)?

  • Heart rate (HR)

  • preload

  • contractility

  • afterload.

58
New cards

How does preload affect stroke volume (SV)?

increased preload → increases SV, according to the Frank-Starling law.

59
New cards

What is the relationship between preload and central venous pressure (CVP) for the right ventricle?

Preload is proportional to CVP.

60
New cards

What happens to stroke volume in diastolic heart failure?

Stroke volume decreases due to stiffer ventricles, even with normal end-diastolic pressure (EDP).

61
New cards

What is contractility and how is it affected in systolic heart failure?

Contractility is the force generated by the ventricles during systole, which is decreased in systolic heart failure.

62
New cards

What is afterload and how is it influenced?

Afterload is the peak systolic stress that must be overcome for blood ejection, influenced by systolic pressure and ventricular radius.

63
New cards

How does high systolic blood pressure affect afterload?

High systolic blood pressure increases afterload.

64
New cards

What role does the RAAS system play in heart failure?

RAAS activation leads to:

  • decreased cardiac output

  • renal perfusion

  • increased renin

  • angiotensin II-induced vasoconstriction

  • aldosterone-mediated sodium and water retention.

<p>RAAS activation leads to:</p><ul><li><p>decreased cardiac output</p></li><li><p>renal perfusion</p></li><li><p>increased renin</p></li><li><p>angiotensin II-induced vasoconstriction</p></li><li><p>aldosterone-mediated sodium and water retention.</p></li></ul><p></p>
65
New cards

What are the effects of sympathetic activation in heart failure?

  • increased heart rate

  • increased contractility

  • vasoconstriction

  • side-note: long-term can lead to cardiac remodeling and worsening heart failure.

66
New cards

What are the main electrophysiological processes targeted by antiarrhythmics?

  • Automaticity 

  • conduction velocity

  • refractoriness.

<ul><li><p>Automaticity&nbsp;</p></li><li><p>conduction velocity</p></li><li><p> refractoriness.</p></li></ul><p></p>
67
New cards

What is automaticity in cardiac tissues?

Automaticity is spontaneous depolarization in nodal tissues due to funny current (If) and occurs in phase 4.

<p>Automaticity is <u>spontaneous depolarizatio</u>n in nodal tissues due to <u>funny current</u> (If) and occurs <u>in phase 4.</u></p>
68
New cards

What is the significance of ectopic foci in arrhythmias?

Ectopic foci can form in diseased myocytes, leading to abnormal pacemaker activity and interference with normal sinus rhythm.

69
New cards

How does conduction velocity relate to cardiac depolarization?

Conduction velocity depends on the slope of phase 0 depolarization, with nodal tissues primarily relying on calcium influx.

70
New cards

What is refractoriness and how is it affected by K+ channel blockade?

Refractoriness is the period during which depolarization is not possible; K+ channel blockade prolongs this period, increasing effective refractory period (ERP).

<p>Refractoriness is the period during which <u>depolarization is not possible</u>; K+ channel <u>blockade</u> prolongs this period, <u>increasing</u> effective refractory period (ERP).</p>
71
New cards

How can arrhythmias be classified by location?

Arrhythmias can be classified as supraventricular (SA, AV, atrial), ventricular, or junctional.

72
New cards

What is the mechanism of enhanced automaticity in arrhythmias?

Enhanced automaticity involves accelerated generation of action potentials by normal pacemaker cells due to increased depolarization.

73
New cards

What are examples of ectopic rhythms?

  • atrial premature beats

  • atrial tachycardias

  • multifocal atrial tachycardia

  • ventricular tachycardia.

74
New cards

What is reentry in the context of arrhythmias?

Reentry is when impulses die out and reentrant impulses circle back to re-excite cardiac regions other than the SA node.

75
New cards

What are examples of reentrant arrhythmias?

  • atrial fibrillation (AF)

  • atrial flutter (AFL)

  • AV node reentry (AVNRT)

  • AV reentry (AVRT)

  • ventricular tachycardia (VT).

76
New cards

How do drugs affect reentry in arrhythmias?

Drugs can suppress reentry by:

  • increasing ERP (Class III, Ia)

  • decreasing conduction velocity (Class Ic, II, IV).

77
New cards

What is the difference between rate control and rhythm control in atrial fibrillation?

  • rate control slows AV conduction (e.g., β-blockers)

  • rhythm control aims to restore sinus rhythm (e.g., Na+ and K+ channel blockers).

<ul><li><p><u>rate </u>control <u>slows </u>AV conduction (e.g., β-blockers)</p></li><li><p><u>rhythm</u> control aims to <u>restore</u> sinus rhythm (e.g., Na+ and K+ channel blockers).</p></li></ul><p></p>
78
New cards

What is the mechanism of loop diuretics in heart failure?

Loop diuretics inhibit Na+/K+/2Cl-reabsorption in the loop of Henle, acting as the strongest diuretics.

79
New cards

What is a potential consequence of excessive diuresis in heart failure?

can worsen cardiac output and activate the RAAS system, leading to vasoconstriction and fluid retention.

80
New cards

What is the mechanism of action of loop diuretics?

They inhibit the Na/K/Cl symporter in the loop of Henle, affecting Ca and Mg levels.

81
New cards

What is the site of action for loop diuretics?

Loop of Henle (LOH).

82
New cards

What are common adverse effects of loop diuretics?

  • hypokalemia/-calcemia/-magnesemia

  • hyperlipidemia

  • ototoxicity

  • sulfa allergy (except ethacrynic acid).

83
New cards

What drug interactions are associated with loop diuretics?

  • NSAIDs → decrease GFR

  • ACE inhibitors/ARBs → decrease GFR

  • corticosteroids → additive hypokalemia

84
New cards

What is the mechanism of action of thiazide diuretics?

They block the Na/Cl cotransporter in the distal convoluted tubule (DCT), enhancing Ca²⁺ reabsorption.

85
New cards

What are examples of thiazide diuretics?

  • Chlorothiazide

  • Chlorthalidone

  • Metolazone.

86
New cards

What is the mechanism of action of potassium-sparing diuretics?

They block aldosterone receptors (Spironolactone, Eplerenone) or inhibit ENaC channels (Amiloride, Triamterene).

87
New cards

What are the adverse effects of Spironolactone?

  • gynecomastia

  • sexual dysfunction.

88
New cards

What is the mechanism of action of ACE inhibitors?

They block the conversion of Angiotensin I to Angiotensin II, increasing bradykinin levels.

89
New cards

What are common adverse effects of ACE inhibitors?

  • dry cough

  • angioedema

  • hyperkalemia

  • hypotension

  • renal dysfunction.

90
New cards

What distinguishes ARBs from ACE inhibitors?

ARBs block AT1 receptors, preventing Ang II from binding, and have less bradykinin effect.

91
New cards

What are the adverse effects of ARBs?

  • Hypotension

  • hyperkalemia

  • renal dysfunction

  • no cough or angioedema.

92
New cards

What is the mechanism of action of beta-blockers?

They block beta-adrenergic receptors, decreasing heart rate and contractility.

<p>They block <u>beta-adrenergic </u>receptors, <u>decreasing</u> heart rate and contractility.</p>
93
New cards

What are common adverse effects of beta-blockers?

  • bradycardia

  • fatigue

  • dizziness

  • withdrawal syndrome.

94
New cards

What is the mechanism of action of digoxin?

It inhibits Na⁺/K⁺ ATPase, increasing intracellular Ca²⁺ and contractility.

95
New cards

What is the therapeutic window for digoxin?

Narrow (0.5-1.0 ng/ml), with toxicity occurring >2 ng/ml.

96
New cards

What are the adverse effects of digoxin toxicity?

  • NVD

  • arrhythmias

  • CNS confusion

  • yellow vision (xanthopsia).

97
New cards

What is the mechanism of action of PDE3 inhibitors like Milrinone?

They increase cAMP levels, leading to increased intracellular Ca²⁺ and vasodilation.

98
New cards

What are the adverse effects of PDE3 inhibitors?

  • headaches

  • hypotension

  • ventricular arrhythmias

  • chest pain.

99
New cards

What are the five classes of antiarrhythmic drugs according to the Vaughan-Williams classification?

  • Class I - Na Channel Blockers

  • Class II - B-Blockers

  • Class III - K Channel Blockers

  • Class IV - Ca Channel Blockers,

  • Class V - Other.

100
New cards

What is the mechanism of Class Ia antiarrhythmics?

They slow depolarization, prolong QRS and QT intervals, and may have anticholinergic effects.